Press Release
PathAI IBD Explore™ panel will empower drug developers with improved inflammatory microenvironment spatial characterization from H&E, propelling a new phase of precision medicine in IBD BOSTON — May 17, 2023 —PathAI, a global...
Clinically Utilized by Labs Throughout the World, the Paige Platform is the Only Digital Pathology Solution Built for AI Offering Flexibility, Scalability, and Customization NEW YORK--(BUSINESS WIRE)--Paige, a global leader in end-to-end...
Collaborative research by Deep Bio and Dr. Lotan research team at Johns Hopkins Medicine was revealed at AUA 2023 SEOUL, SOUTH KOREA (PRWEB) MAY 11, 2023 - Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics support...
Lunit and collaborators demonstrate the predictive value and analytical prowess of Lunit's AI-biomarker platform in a wide range of cancer types and clinical practices SEOUL, South Korea, May 10, 2023 /PRNewswire/ -- Lunit...
NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a EUR 1.300.000 EFRO-OOST grant alongside Radboud university medical center and Pathologie-DNA to...
The Institute of Human Biology aims to better predict which drug candidates are safe and most effective in patients by evolving and increasing the use of human model systems. Human model systems are miniature living 'replicas' of...
